Current Funding Opportunities

To visit the NCI grant site, click here


Use your device's search function to find a specific disease or funding source. 


Brain


The Sontag Foundation
The Sontag Foundation’s Distinguished Scientist Award (DSA) seeks to provide career and research support to early career scientists who demonstrate outstanding promise for making scientific and medical breakthroughs in the field of brain cancer research.

Recipients of the award are inspired individuals with projects that show potential to generate new knowledge relating to causes, cure or treatment of primary brain tumors/brain cancer. Applicants are carefully considered and selected by The Sontag Foundation and its independent Scientific Advisory Board based on the scientific merit of the proposed project, career trajectory, peer and mentor references and an onsite research facility visit. In determining the overall scientific merit of an application, the Scientific Advisory Board scores applications based on the NIH review criteria of: significance, investigator, innovation, approach, and environment.

The award provides $600,000 in funding over a four-year period. Over that time, recipients also receive additional support from the Foundation through its vast network of scientists in the field primarily through the Foundation's annual Scientific Retreat.

Application Deadline: March 14, 2018

Learn More>>

Breast 


Breast Cancer Alliance  
The mission of the Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment, and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support, and screening for the underserved. 

Four types of grants are offered annually: Exceptional Project Grants, Young Investigator Grants, Breast Surgery Fellowships, and Education and Outreach Grants. We invite clinical doctors and research scientists whose primary focus is breast cancer research to apply for either the Exceptional Project or Young Investigator Grant. Society of Surgical Oncology-accredited institutions may submit requests for funding for fellowships if they are in CT, NJ, or NY. We invite Directors of programs that are directly related to breast cancer services to apply for the Education and Outreach Grant.

  - Exceptional Project Grants

BCA invites clinical doctors and research scientists at any stage of their careers whose primary focus is breast cancer to apply for an Exceptional Project Grant. This award recognizes creative, unique, and innovative research and is open to applicants throughout the US. This is a one-year grant for a total of $100,000.

Prior to submission of a formal grant proposal, the BCA requires a one-page Letter of Intent (LOI) and a separate CV. For 2019 grants, those letters will be due on April 6, 2018. 

Application Deadlines: Letter of Intent: April 6, 2018; Full Application: July 20, 2018

For more information, contact Susan Hanchard. 




  - Young Investigator Grants

To encourage a commitment to breast cancer research, BCA invites clinical doctors and research scientists whose primary focus is breast cancer and who are in the early stages of their careers to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions throughout the US. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.

Applicants for 2019 grants must (i) have held a faculty position for no more than four years following completion of their training, as of February 1, 2019; (ii) have not been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research.

This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support.

Application Deadline: July 20, 2018 

For more information, contact Susan Hanchard. 


  - Education and Outreach Grants

BCA offers grants to support programs directly related to outreach and case managerial breast cancer services, including education, counseling, and mammograms for the uninsured/underserved. The programs must be located in CT and/or Westchester County, NY.

The term of the Education and Outreach Grant is one calendar year beginning February 1, 2019. The program must be directly related to breast cancer services. BCA does not fund office supplies, medical supplies, financial aid (i.e., gas bills, transportation, rent, overhead, grocery gift certificates, fringe benefits, etc.), printing costs, travel costs, marketing costs, recruitment costs, or training programs.

Application Deadline: October 31, 2018

For more information, contact Susan Hanchard. 


  - Breast Surgery Fellowships

The term of the Breast Surgical Fellowship is one year with a grant award of $75,000, from August 1 through July 31.  Institutions making application for the 2019 award must have an established breast fellowship program, be SSO accredited for a minimum of 2 years, and be located in Connecticut, New Jersey, or New York.  

Application Deadline: December 10, 2018

For more information, contact Susan Hanchard. 

Ovarian

Defense Health Program: Department of Defense Ovarian Cancer Research Program - Anticipated Funding Opportunities for Fiscal Year 2018 (FY18) 

*Although funds have not been appropriated for the FY18 Department of Defense Ovarian Cancer Research Program (OCRP), the OCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY18 funding opportunities.

FY18 OCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in March 2018. Pre-application and application deadlines will be available when the Program Announcements are released. 

This pre-announcement should not be construed as an obligation by the Government, and funding of research projects received in response to these Program Announcements is contingent on the availability of federal funds appropriated for the OCRP. 

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate, manages the Defense Health Program Research, Development, Test, and Evaluation appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP). The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service members, Veterans, retirees, their family members, and all women impacted by this disease.

Clinical Development Award
• Must be an independent investigator at or above the level of Assistant Professor (or equivalent).
• Supports the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life.
• Near-term impact is expected.
• Preclinical studies in animals are not allowed.
• Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed.
• Preliminary data are required.
Optional Nested Early-Career Investigator (ECI): Applications proposing clinical trials and having an ECI that meets the criteria outlined in the Program Announcement/Funding Opportunity will qualify for a higher level of funding.
• Submission of a Letter of Intent is required prior to full application submission.
• Maximum funding of $600,000 for direct costs (plus indirect costs).
• With ECI option the maximum funding is $800,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.

Omics Consortium Development Award
• Must be an independent investigator at the Associate Professor level or above (or equivalent)
• Supports a multi-institutional research effort conducted by leading cancer researchers and advocates that focuses on the origin of ovarian cancer, with an emphasis on risk stratification, screening and early detection.
• Funds support assembling consortium members and laying the groundwork for the research project, including proof of concept.
• Ovarian cancer advocate(s) are required on the research team.
• Funded applicants will be eligible to compete for the consortium award, which will support the execution of the full research project and is anticipated to be offered in FY20, pending availability of funds.
• Submission of a Letter of Intent is required prior to full application submission
• Maximum funding of $400,000 for direct costs (plus indirect costs).
• Period of performance not to exceed 2 years.

Investigator-Initiated Research Award
• Must be an independent investigator at or above the level of Assistant Professor (or equivalent).
• Supports meritorious basic and clinically oriented research in ovarian cancer.
• Impact is an important review criterion.
• Preliminary data are required.
• Clinical trials are not allowed.
• Pre-application is required; application is by invitation only.
• Maximum funding of $450,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.

Ovarian Cancer Academy Award – Early-Career Investigator
• Must be within 3 years of his/her last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equivalent as of the full application submission deadline. A letter attesting to eligibility is required.
• Supports the addition of new ECIs to the unique, interactive virtual academy that provides intensive mentoring, national networking, and a peer group for junior faculty.
• ECIs whose ability to commit to conducting ovarian cancer research is limited by lack of resources or other overwhelming obstacles are encouraged to apply.
• A Designated Mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required.
• A Designated Mentor may only mentor one ECI candidate.
• The Designated Mentor is not required to be at the same institution as the ECI.
• Preliminary data are required.
• Clinical trials are allowed.
• Submission of a Letter of Intent is required prior to full application submission.
• Maximum funding of $725,000 for direct costs (plus indirect costs).
• Maximum period of performance is 4 years.

Pilot Award
• Investigators at or above the postdoctoral level (or equivalent).
• Supports innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward.
• Innovation and Impact are important review criteria.
• Goal is to develop preliminary data; thus, preliminary data are not required, but are allowed.
• Clinical trials are not allowed.
• Pre-application is required and blinded; application submission is by invitation only.
• Maximum funding of $250,000 for direct costs (plus indirect costs).
• Maximum period of performance is 2 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the Federal Government’s single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, go to the CDMRP website (http://cdmrp.army.mil) and select Subscribe to Funding Opportunities & Program Communications. For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Pancreatic

The Pancreatic Cancer Detection Consortium (U01) 
This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions.

Application Due Date: April 6, 2018

Learn More>>

Department of Defense Ovarian Cancer Research Program

Defense Health Program: Department of Defense Ovarian Cancer Research Program - Anticipated Funding Opportunities for Fiscal Year 2018 (FY18) 

*Although funds have not been appropriated for the FY18 Department of Defense Ovarian Cancer Research Program (OCRP), the OCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY18 funding opportunities. 

FY18 OCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in March 2018. Pre-application and application deadlines will be available when the Program Announcements are released. 

This pre-announcement should not be construed as an obligation by the Government, and funding of research projects received in response to these Program Announcements is contingent on the availability of federal funds appropriated for the OCRP. 

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate, manages the Defense Health Program Research, Development, Test, and Evaluation appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service members, Veterans, retirees, their family members, and all women impacted by this disease.

Clinical Development Award
• Must be an independent investigator at or above the level of Assistant Professor (or equivalent).
• Supports the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life.
• Near-term impact is expected.
• Preclinical studies in animals are not allowed.
• Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed.
• Preliminary data are required.
Optional Nested Early-Career Investigator (ECI): Applications proposing clinical trials and having an ECI that meets the criteria outlined in the Program Announcement/Funding Opportunity will qualify for a higher level of funding.
• Submission of a Letter of Intent is required prior to full application submission.
• Maximum funding of $600,000 for direct costs (plus indirect costs).
• With ECI option the maximum funding is $800,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.

Omics Consortium Development Award
• Must be an independent investigator at the Associate Professor level or above (or equivalent)
• Supports a multi-institutional research effort conducted by leading cancer researchers and advocates that focuses on the origin of ovarian cancer, with an emphasis on risk stratification, screening and early detection.
• Funds support assembling consortium members and laying the groundwork for the research project, including proof of concept.
• Ovarian cancer advocate(s) are required on the research team.
• Funded applicants will be eligible to compete for the consortium award, which will support the execution of the full research project and is anticipated to be offered in FY20, pending availability of funds.
• Submission of a Letter of Intent is required prior to full application submission
• Maximum funding of $400,000 for direct costs (plus indirect costs).
• Period of performance not to exceed 2 years.

Investigator-Initiated Research Award
• Must be an independent investigator at or above the level of Assistant Professor (or equivalent).
• Supports meritorious basic and clinically oriented research in ovarian cancer.
• Impact is an important review criterion.
• Preliminary data are required.
• Clinical trials are not allowed.
• Pre-application is required; application is by invitation only.
• Maximum funding of $450,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.

Ovarian Cancer Academy Award – Early-Career Investigator
• Must be within 3 years of his/her last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equivalent as of the full application submission deadline. A letter attesting to eligibility is required.
• Supports the addition of new ECIs to the unique, interactive virtual academy that provides intensive mentoring, national networking, and a peer group for junior faculty.
• ECIs whose ability to commit to conducting ovarian cancer research is limited by lack of resources or other overwhelming obstacles are encouraged to apply.
• A Designated Mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required.
• A Designated Mentor may only mentor one ECI candidate.
• The Designated Mentor is not required to be at the same institution as the ECI.
• Preliminary data are required.
• Clinical trials are allowed.
• Submission of a Letter of Intent is required prior to full application submission.
• Maximum funding of $725,000 for direct costs (plus indirect costs).
• Maximum period of performance is 4 years.

Pilot Award
• Investigators at or above the postdoctoral level (or equivalent).
• Supports innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward.
• Innovation and Impact are important review criteria.
• Goal is to develop preliminary data; thus, preliminary data are not required, but are allowed.
• Clinical trials are not allowed.
• Pre-application is required and blinded; application submission is by invitation only.
• Maximum funding of $250,000 for direct costs (plus indirect costs).
• Maximum period of performance is 2 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the Federal Government’s single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, go to the CDMRP website (http://cdmrp.army.mil) and select Subscribe to Funding Opportunities & Program Communications. For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Leidos Biomedical Research

Request for Proposal S18-054 “Prototyping Carrier Basket Arrays” (RFP)

Leidos Biomedical Research, Inc. (Leidos Biomed) is issuing the RFP and will be responsible for awarding the resulting Agreement(s), in support of the Division of Cancer Treatment & Diagnosis, National Cancer Institute (NCI). Leidos Biomed is the Operations and Technical Support Services Contractor of the Frederick National Laboratory for Cancer Research, which solely supports the NCI mission.

The RFP seeks proposals to use shape-changing materials (“smart materials”) to create an arrayed carrier suitable for transporting 3-dimensional mammalian organoid cultures from multi-well cell culture plates into common histology cassettes. The idea to use shape-changing materials and similar strategies that precisely control shape and size changes stems from the need to convert the size of the array from the standard dimensions of multi-well cell culture plates (127.76 x 85.48 x 14.35 mm, per The Society for Laboratory Automation and Screening (https://www.slas.org/SLAS/assets/File/ANSI_SLAS_1-2004_FootprintDimensions.pdf) into the standard dimensions of histology cassettes (24 x 30 x 11 mm), in order that 3D organoid cultures can be processed en masse into a paraffin block for sectioning onto slides and immuno/histochemical analysis.

The Project Objective is to design and prototype carriers that can readily bridge these two standardized systems by shrinking, expanding, or both, without perturbing the payload of 3D organoids being transported. The RFP represents the initial stage of the Project and, therefore, focuses on identification of candidate materials and the design, limited production and testing of prototypes; successful prototypes will play an important role in proving feasibility of the approach. You are invited to submit a proposal in accordance with the requirements of the RFP.

The RFP Package consists of two attachments: (i) the first is the RFP document, which includes instructions for preparing the proposal; and (ii) the second is the Agreement document, which is provided in advance of award to allow time to review the terms and conditions.

The issuance of the RFP is the first step in a multi-step process, which will culminate in the receipt of proposals. In between now and March 15, 2018, two “Bidders’ Teleconferences” have been scheduled: (i) 12:15 pm (EST) on Thursday, February 22, 2018; and (ii) 3:15 pm (EST) on Wednesday, March 7, 2018. These teleconferences will provide a venue to ask and receive answers to questions regarding the RFP, the proposal and subcontracting processes, the technical project’s nature and scope, and other related topics. You can join the teleconferences by calling 855.462.5367, passcode 8936166.

Application Deadline:
March 15, 2018 by 2:00 p.m. EST - proposals will not be accepted after 2:00 p.m. EST



Pancreatic Cancer Action Network

The Pancreatic Cancer Detection Consortium (U01)   
This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions. 

Application Due Date: April 6, 2018 

Learn More>>


The Sontag Foundation


The Sontag Foundation’s Distinguished Scientist Award (DSA) seeks to provide career and research support to early career scientists who demonstrate outstanding promise for making scientific and medical breakthroughs in the field of brain cancer research. 

Recipients of the award are inspired individuals with projects that show potential to generate new knowledge relating to causes, cure or treatment of primary brain tumors/brain cancer. Applicants are carefully considered and selected by The Sontag Foundation and its independent Scientific Advisory Board based on the scientific merit of the proposed project, career trajectory, peer and mentor references and an onsite research facility visit. In determining the overall scientific merit of an application, the Scientific Advisory Board scores applications based on the NIH review criteria of: significance, investigator, innovation, approach, and environment. 

The award provides $600,000 in funding over a four-year period. Over that time, recipients also receive additional support from the Foundation through its vast network of scientists in the field primarily through the Foundation's annual Scientific Retreat. 

Application Deadline: March 14, 2018

Learn More>>

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants. 


Pilot Funding Opportunity: American Cancer Society Institutional Research Grant

Yale Cancer Center is pleased to announce the 2018 ACS-IRG competition for Yale Assistant Professors to support innovative work in the broad fields of basic, translational, clinical, and prevention/control cancer research.

One year grants will provide up to $30,000 for each award. YCC members and non-members are encouraged to apply.

Eligibility:
- Must be an Assistant Professor
- Must not have already received federal research grant support or a previous ACS-IRGaward
- All applicants must identify a faculty mentor who has expertise in cancer research

Application Due Date: February 28, 2018

Learn More>>



Leslie H. Warner Postdoctoral Fellowships

• Fellowships to support innovative basic, translational, clinical, or population-based cancer research.
• Candidates may have up to one year postdoctoral experience.
• Not restricted to U.S. Citizens or permanent residents

Application Due Date:
March 1, 2018; To apply, please click here


James Hudson Brown - Alexander Brown Coxe Postdoctoral Fellowships in the Medical Sciences 2018

The Brown-Coxe Fellowships support early postdoctoral fellows conducting research at the Yale University School of Medicine.

      • No citizenship restrictions.
      • Investigators in all disciplines conducting basic, translational, or clinical research are eligible for this fellowship. (Licensed) physician-scientists are encouraged to apply. 
      • Applicants cannot have completed more than two years of postdoctoral research as of July 1, 2018.
      • Candidates must have received the MD, PhD, or other doctoral degree by July 1, 2018.

Application Due Date: 
Letter of intent: March 8, 2018; Application deadline: March 15, 2018

empty
empty
empty empty empty empty empty empty empty empty


Breast Cancer Alliance
  
The mission of the Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment, and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support, and screening for the underserved.  

Four types of grants are offered annually: Exceptional Project Grants, Young Investigator Grants, Breast Surgery Fellowships, and Education and Outreach Grants. We invite clinical doctors and research scientists whose primary focus is breast cancer research to apply for either the Exceptional Project or Young Investigator Grant. Society of Surgical Oncology-accredited institutions may submit requests for funding for fellowships if they are in CT, NJ, or NY. We invite Directors of programs that are directly related to breast cancer services to apply for the Education and Outreach Grant.

- Exceptional Project Grants (Open to all faculty) 

- $100,000 for one year (Total: $100,000)
- For clinical doctors and research scientists whose primary focus is breast cancer
- Candidates are eligible at any stage of their careers
- The proposed research must be directly related to the field of breast cancer
- Areas of relevant research may include, but are not limited to: diagnosis, etiology, immunology, genetics, therapies, prevention, and clinical studies  


Application Deadlines: 
Internal deadline: March 5, 2018

To apply, click here.

For more information, please click here. Questions, please contact Susan Hanchard.


- Young Investigator Grants 

To encourage a commitment to breast cancer research, BCA invites clinical doctors and research scientists whose primary focus is breast cancer and who are in the early stages of their careers to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions throughout the US. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.

Applicants for 2019 grants must (i) have held a faculty position for no more than four years following completion of their training, as of February 1, 2019; (ii) have not been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research.

This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support.

Application Deadline: July 20, 2018 

For more information, contact Susan Hanchard.


  - Education and Outreach Grants 

BCA offers grants to support programs directly related to outreach and case managerial breast cancer services, including education, counseling, and mammograms for the uninsured/underserved. The programs must be located in CT and/or Westchester County, NY.

The term of the Education and Outreach Grant is one calendar year beginning February 1, 2019. The program must be directly related to breast cancer services. BCA does not fund office supplies, medical supplies, financial aid (i.e., gas bills, transportation, rent, overhead, grocery gift certificates, fringe benefits, etc.), printing costs, travel costs, marketing costs, recruitment costs, or training programs.

Application Deadline: October 31, 2018 




  - Breast Surgery Fellowships
 
The term of the Breast Surgical Fellowship is one year with a grant award of $75,000, from August 1 through July 31.  Institutions making application for the 2019 award must have an established breast fellowship program, be SSO accredited for a minimum of 2 years, and be located in Connecticut, New Jersey, or New York.  

Application Deadline: 
December 10, 2018



Lion Heart Grants
  • Funding amount based on fundraising annually done by Lion Hearts
  • For Yale Cancer Center members only 
  • To support breast cancer research
  • Committee of Yale Cancer Center members and Lion Heart members review and select grant recipients
  • Administered by Brigid Killelea


SPORE in Lung Cancer Program Awards

Learn More>>

LungSPORE@yale.edu     


V Foundation Pediatric Cancer Grants
  • ONE NOMINEE TO APPLY FOR EITHER THE V SCHOLAR OR TRANSLATIONAL AWARD
  • The nominee must be nominated by their Cancer Center Director if the research institution is a cancer center. If the research institution is not a cancer center, then the department chair or other senior research administrative official who is responsible for the internal nominee 
  • Applicant must be employed at a non-profit research institution 
  • Administered by Gary Kupfer

American Cancer Society Institutional Research Grants
  • $30,000 for one year
  • For assistant professors only
  • Prior national research grant disqualifies
  • Four awards per year
  • Usually reviewed in December
  • Administered by Joann Sweasy

Rausch Foun dation Grants in Community Health
  • $30,000-$50,000 for one year
  • Population science focus
  • Priority to projects with impact to New Haven
  • Administered by Melinda Irwin 

YCC Pilot Grants
  • $50,000 for one year
  • All YCC members eligible to apply
  • Specific project proposed by individual investigator
  • Seven or eight awards per year, distributed among all seven research programs
  • Usually reviewed in Spring
  • Administered by Joann Sweasy
  • For more information, please contact Jan Zulkeski

T-TARE Award
  • Up to $200,000 for one year
  • For teams of investigators
  • Research with a translational focus
  • Major goal is to generate data and evidence of collaboration for multi-investigator grant application
  • Administered by Roy Herbst

Yale Discovery Fund Grants 

  • $450,000 to be spent over three years
  • High-risk/high-reward cancer research
  • Multidisciplinary collaborative research
  • Hope to fund 3 – 4 each year
  • Administered by Dan DiMaio

Leslie Warner Postdoctoral Fellowship
  • ~$42,000 for one year
  • Fellows working in YCC member laboratories eligible to apply
  • Must be in first year of fellowship
  • Four awards every other year
  • Usually reviewed in fall
  • Review organized by Karen Anderson